Home・Akciju saraksts・Zimmer Biomet Holdings Inc

Zimmer Biomet Holdings Inc

Atvērts

SektorsVeselības aprūpe

95.59 -0.94

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

94.16

Max

96.98

Galvenie mērījumi
By Trading Economics
Ienākumi	99M 239M
Pārdošana	-157M 2.1B
P/E Sektora vidējais	23.852 64.641
EPS	2.09
Dividenžu ienesīgums	1.05
Peļņas marža	11.43
Darbinieki	17,000
EBITDA	84M 538M

Rekomendācijas
By TipRanks
Rekomendācijas	Pirkt
Prognoze 12 mēnešiem	+2.66% upside

Dividendes
By Acuity
Dividenžu ienesīgums Sektora vidējais	1.05% 2.31%
Nākamie ieņēmumi	2026. g. 5. aug.
Nākamais dividenžu datums	2026. g. 30. okt.
Nākamais Ex dividenžu datums	2026. g. 29. sept.

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	-110M 18B
Iepriekšējā atvēršanas cena	96.53
Iepriekšējā slēgšanas cena	95.59

Ziņu noskaņojums

By Acuity

31%

69%

97 / 340 Rangs Healthcare

Zimmer Biomet Holdings Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 3. aug. 23:11 UTC

Shares of Zimmer Biomet Holdings Inc. are lower in after-market hours, showing weakness despite earlier gains and remaining above their 20-day moving average.

2026. g. 31. jūl. 20:06 UTC

Correlated Moves

Zimmer Biomet Holdings Inc. shares are lower today, influenced by Stryker Corp's decline and broader market sentiment amid rising Treasury yields and inflation concerns.

2026. g. 30. jūl. 19:03 UTC

Zimmer Biomet Holdings Inc shares are lower today, breaking a trend of higher closes. Broader economic indicators may contribute to market uncertainty.

2026. g. 29. jūl. 17:46 UTC

Zimmer Biomet Holdings Inc shares are higher, continuing a positive trend since Tuesday's close. Broader market volatility is impacting sentiment amid rising oil prices.

2026. g. 28. jūl. 20:03 UTC

News

Social Media

UBS initiated coverage on Zimmer Biomet with a Buy rating and a $115 price target, supporting shares' advance during the current trading session.

2026. g. 27. jūl. 18:46 UTC

Correlated Moves

Zimmer Biomet Holdings Inc is advancing in Monday's session, supported by a broader rise in the medical devices sector amid declining crude oil prices.

2026. g. 24. jūl. 19:06 UTC

Correlated Moves

Zimmer Biomet Holdings is trading higher, benefiting from a pullback in crude oil prices and positive sentiment in the health care equipment sector.

2026. g. 23. jūl. 21:02 UTC

Zimmer Biomet Holdings Inc shares are lower in after-market hours. No specific news was identified to explain the price movement.

2026. g. 22. jūl. 18:36 UTC

Correlated Moves

Zimmer Biomet Holdings Inc reported first-quarter adjusted EPS of $1.08, below estimates. Shares are lower today amid broader sector declines and external market pressures.

2026. g. 20. jūl. 18:16 UTC

Zimmer Biomet Holdings Inc shares are lower amid unusual volatility and broader market concerns over rising yields and inflation fears linked to increasing oil prices.

Salīdzinājums

Cenas izmaiņa

Zimmer Biomet Holdings Inc Prognoze

Cenas mērķis

By TipRanks

2.66% augšup

Prognoze 12 mēnešiem

Vidējais 99.56 USD 2.66%

Augstākais 115 USD

Zemākais 83 USD

Pamatojoties uz 10 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Zimmer Biomet Holdings Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

10 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 10 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Zimmer Biomet Holdings Inc — pēdējo 3 mēnešu laikā.

Noskaņojums

By Acuity

97 / 340 Rangs Veselības aprūpe

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par Zimmer Biomet Holdings Inc

Zimmer Biomet Holdings, Inc. is a global medical technology company. Its segments include Americas, EMEA, and Asia Pacific. The Company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; craniomaxillofacial and thoracic (CMFT) products; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its other product category primarily includes its robotic, surgical and bone cement products. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee, and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System, and G7 Acetabular System. Its S.E.T. product category includes sports medicine, biologics, foot and others.